Please try another search
For the three months ended 31 March 2018, Foundation Medicine Inc revenues increased from $26.3M to $52.8M. Net loss decreased 19% to $37.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Stock-based Compensation in G&A decrease of 54% to $1.3M (expense), Stock-based Compensation in R&D decrease of 41% to $777K (expense).
Period Ending: | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
---|---|---|---|---|
Total Revenue | 52.84 | 48.91 | 42.66 | 35 |
Gross Profit | 25.61 | 22.37 | 23.53 | 13.42 |
Operating Income | -36.42 | -37.52 | -32.43 | -44.31 |
Net Income | -37.41 | -38.11 | -32.64 | -44.26 |
Period Ending: | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
---|---|---|---|---|
Total Assets | 177.16 | 169 | 150.56 | 146.37 |
Total Liabilities | 158.27 | 137.34 | 87.12 | 56.85 |
Total Equity | 18.9 | 31.67 | 63.44 | 89.52 |
Period Ending: | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -38.89 | -120.99 | -89.13 | -67 |
Cash From Investing Activities | -5.68 | 62.83 | 68.51 | 37.69 |
Cash From Financing Activities | 33.43 | 65.95 | 33.8 | 2.19 |
Net Change in Cash | -11.11 | 7.79 | 13.2 | -27.09 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review